Sterile Diluent — Class II drug recall D-0445-2024
Completed recall by Eli Lilly & Company, reported 2024-04-24, distributed nationwide. CGMP Deviations
| Recall number | D-0445-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Eli Lilly & Company, Indianapolis, IN, United States |
| Recall initiated | 2024-03-12 |
| Classified | 2024-04-17 |
| Reported by FDA | 2024-04-24 |
| Distributed | Nationwide (US) |
| Quantity | 700 vials |
| Reason classes | cgmp |
| NDC | 00002-0800, 00002-0800-01, 00002-7510, 00002-7510-01, 00002-7510-17, 00002-7516, 00002-7516-01, 00002-7516-59, 00002-7516-99, 00002-7533, 00002-7533-01, 00002-7712, 00002-7712-01, 00002-7712-27, 00002-7712-61, 00002-7714, 00002-7714-01, 00002-7714-59, 00002-7714-61, 00002-8213, 00002-8213-01, 00002-8213-05, 00002-8799, 00002-8799-01, 00002-8799-59 |
| Lot numbers | D608951C |
| Expiration dates | 2025-04-10 |
Product
Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285. NDC: 0002-0800-01
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0445-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.